Tissue | Expression Dynamics | Abbreviation |
Esophagus | | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0031647111 | Esophagus | ESCC | regulation of protein stability | 223/8552 | 298/18723 | 5.76e-25 | 1.52e-22 | 223 |
GO:003450418 | Esophagus | ESCC | protein localization to nucleus | 211/8552 | 290/18723 | 4.06e-21 | 6.60e-19 | 211 |
GO:00062604 | Esophagus | ESCC | DNA replication | 181/8552 | 260/18723 | 3.55e-15 | 2.05e-13 | 181 |
GO:0050821111 | Esophagus | ESCC | protein stabilization | 140/8552 | 191/18723 | 6.50e-15 | 3.61e-13 | 140 |
GO:199017316 | Esophagus | ESCC | protein localization to nucleoplasm | 14/8552 | 14/18723 | 1.71e-05 | 1.52e-04 | 14 |
GO:00316477 | Liver | NAFLD | regulation of protein stability | 61/1882 | 298/18723 | 5.00e-08 | 4.71e-06 | 61 |
GO:00508217 | Liver | NAFLD | protein stabilization | 40/1882 | 191/18723 | 5.38e-06 | 1.95e-04 | 40 |
GO:00345046 | Liver | NAFLD | protein localization to nucleus | 45/1882 | 290/18723 | 2.16e-03 | 2.10e-02 | 45 |
GO:003164712 | Liver | Cirrhotic | regulation of protein stability | 144/4634 | 298/18723 | 6.74e-19 | 1.28e-16 | 144 |
GO:005082112 | Liver | Cirrhotic | protein stabilization | 97/4634 | 191/18723 | 6.67e-15 | 6.97e-13 | 97 |
GO:003450411 | Liver | Cirrhotic | protein localization to nucleus | 113/4634 | 290/18723 | 5.00e-08 | 1.58e-06 | 113 |
GO:19901733 | Liver | Cirrhotic | protein localization to nucleoplasm | 12/4634 | 14/18723 | 2.84e-06 | 5.08e-05 | 12 |
GO:003164722 | Liver | HCC | regulation of protein stability | 211/7958 | 298/18723 | 2.29e-23 | 5.01e-21 | 211 |
GO:005082122 | Liver | HCC | protein stabilization | 139/7958 | 191/18723 | 1.61e-17 | 1.71e-15 | 139 |
GO:003450421 | Liver | HCC | protein localization to nucleus | 194/7958 | 290/18723 | 2.84e-17 | 2.85e-15 | 194 |
GO:00062601 | Liver | HCC | DNA replication | 146/7958 | 260/18723 | 5.68e-06 | 7.02e-05 | 146 |
GO:199017311 | Liver | HCC | protein localization to nucleoplasm | 13/7958 | 14/18723 | 1.25e-04 | 1.03e-03 | 13 |
GO:00316478 | Lung | IAC | regulation of protein stability | 62/2061 | 298/18723 | 5.37e-07 | 3.32e-05 | 62 |
GO:00345047 | Lung | IAC | protein localization to nucleus | 50/2061 | 290/18723 | 8.71e-04 | 1.11e-02 | 50 |
GO:00508218 | Lung | IAC | protein stabilization | 34/2061 | 191/18723 | 3.21e-03 | 2.78e-02 | 34 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TBRG1 | SNV | Missense_Mutation | | c.985G>A | p.Asp329Asn | p.D329N | Q3YBR2 | protein_coding | tolerated(0.15) | benign(0.015) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TBRG1 | insertion | Nonsense_Mutation | novel | c.988_989insCATCCACAACCTGATCCAGAGCTGTCCAGGAGCTCGAAAATGCATCAA | p.Gly330delinsAlaSerThrThrTerSerArgAlaValGlnGluLeuGluAsnAlaSerArg | p.G330delinsASTT*SRAVQELENASR | Q3YBR2 | protein_coding | | | TCGA-A2-A0D1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | taxotere | SD |
TBRG1 | insertion | Frame_Shift_Ins | novel | c.681_682insTTCAAAACATTTAAGCAATCCTCAC | p.Pro228PhefsTer29 | p.P228Ffs*29 | Q3YBR2 | protein_coding | | | TCGA-AN-A04D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TBRG1 | insertion | Nonsense_Mutation | novel | c.1041_1042insCCTCTCTCCTTCCTTCTTGAGGATTGATCTCATTGCTCG | p.Ala347_Phe348insProLeuSerPheLeuLeuGluAspTerSerHisCysSer | p.A347_F348insPLSFLLED*SHCS | Q3YBR2 | protein_coding | | | TCGA-AO-A0JB-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphamide | SD |
TBRG1 | insertion | Nonsense_Mutation | novel | c.281_282insCACTGCCCAGGGCTCGGAAAGAACGATACTTTGA | p.Ala95ThrfsTer11 | p.A95Tfs*11 | Q3YBR2 | protein_coding | | | TCGA-B6-A0I8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
TBRG1 | SNV | Missense_Mutation | | c.469N>C | p.Cys157Arg | p.C157R | Q3YBR2 | protein_coding | tolerated(0.16) | benign(0.013) | TCGA-JX-A3Q8-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TBRG1 | SNV | Missense_Mutation | rs766145884 | c.538N>T | p.Arg180Trp | p.R180W | Q3YBR2 | protein_coding | deleterious(0.01) | possibly_damaging(0.727) | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TBRG1 | SNV | Missense_Mutation | novel | c.857T>G | p.Leu286Arg | p.L286R | Q3YBR2 | protein_coding | tolerated(0.26) | benign(0.125) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
TBRG1 | SNV | Missense_Mutation | rs761393184 | c.500G>A | p.Arg167His | p.R167H | Q3YBR2 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
TBRG1 | SNV | Missense_Mutation | novel | c.184N>A | p.Leu62Ile | p.L62I | Q3YBR2 | protein_coding | tolerated(0.17) | benign(0.158) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |